CurrentCurativePolicy CHP-IP-2026-016

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Customize your policy alerts

Sign up for curative Policy CHP-IP-2026-016 alerts

Get alerted when Policy CHP-IP-2026-016 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Medical-necessity criteria for outpatient treatment, observation, acute inpatient admission, level-of-care assignment, continued stay, and discharge readiness for Curative commercial members age 18 and older with acute COPD exacerbation, including acute hypercapnic respiratory failure treated with noninvasive or invasive ventilation.

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentCurativePolicy CHP-IP-2026-016

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Customize your policy alerts

Sign up for curative Policy CHP-IP-2026-016 alerts

Get alerted when Policy CHP-IP-2026-016 changes without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerCurative

PolicyAcute Exacerbation of Chronic Obstructive Pulmonary Disease

Policy CodePolicy CHP-IP-2026-016

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionFor acute inpatient admission, document at least one qualifying clinical severity finding and at least one required hospital-level service.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

pH <7.35Acute respiratory acidosis

pH <7.25ICU respiratory threshold

88–92%Controlled oxygen target

2–4 daysUncomplicated stay

24 hoursContinued-stay review

5 daysPrednisone course

Medical Necessity and Level-of-Care Criteria

Acute inpatient admission

Covered when ALL of the following are met:

Clinical severity finding
- Severity findings: Acute respiratory acidosis with pH below 7.35 and PaCO2 above 45 mm Hg; SpO2 below 88% on room air, or below 88-90% on usual home oxygen, not corrected by low-flow oxygen at 2-3 L/min; new confusion, drowsiness, or other mental-status change; severe dyspnea at rest with respiratory rate of 30 or more, accessory muscle use, or inability to speak in sentences persisting after initial emergency treatment; moderate exacerbation that fails to respond to initial emergency bronchodilator and corticosteroid therapy over 4-6 hours; new cyanosis, peripheral edema, arrhythmia, or a serious decompensated comorbidity; or a DECAF score of 3 or more.
Hospital-level service: At least one of the following hospital-level services must be required: noninvasive ventilation for acute hypercapnic respiratory failure; high-flow nasal oxygen or invasive mechanical ventilation; bronchodilators more often than every 4 hours with monitoring; controlled oxygen with repeat arterial or venous blood gas monitoring; intravenous therapy because oral medication cannot be taken; or treatment of a decompensated comorbidity requiring inpatient care.

Observation or outpatient instead of inpatient

Covered when ANY of the following applies:

Outpatient or observation management

Mild exacerbation: Dyspnea score below 5, respiratory rate below 24, heart rate below 95, SpO2 of at least 92% with a fall of 3% or less, and C-reactive protein below 10 mg/L; treat with outpatient short-acting bronchodilators with or without oral corticosteroid and antibiotic.
Moderate exacerbation responsive to emergency treatment: Moderate exacerbation responds to emergency treatment; SpO2 is 88-92% on 3 L/min or less or usual oxygen; pH is 7.35 or higher; the member is alert, can take oral medication, and has adequate home support; and observation is expected to result in discharge within 48 hours.SpO2 88-92%; pH >=7.35; generally under 48 hours
Low-risk early supported discharge: DECAF score is 0-1 and home support is available; early supported discharge or hospital-at-home may be used when offered by the plan.

Intensive care unit

Covered when ANY of the following is present:

ICU care: Severe dyspnea responding inadequately to initial emergency therapy; persistent or worsening hypoxemia or respiratory acidosis despite oxygen and noninvasive ventilation; invasive mechanical ventilation or need for intubation; change in mental status, including confusion, lethargy, or coma; or hemodynamic instability requiring vasopressors.PaO2 <40 mm Hg or pH <7.25 despite oxygen and noninvasive ventilation

Step-down or intermediate care

Covered when no ICU criterion is met and ANY of the following is present:

Step-down or respiratory intermediate care: Noninvasive ventilation for pH 7.25-7.35 with improvement at the 1-2 hour reassessment; high-flow nasal oxygen with stable gas exchange; or weaning from noninvasive ventilation within the previous 24 hours.pH 7.25-7.35 with improvement at 1-2 hours

Medical-surgical unit

Covered when continued acute care is needed and no ICU or step-down criterion is met, including ANY of the following:

Medical-surgical care: Bronchodilators every 2-4 hours with controlled low-flow oxygen; or systemic corticosteroids and antibiotics with oxygen weaning.Bronchodilators every 2-4 hours

Discharge readiness

Covered when ALL of the following are met:

Clinical stability and function: Short-acting bronchodilator is needed no more often than every 4 hours; SpO2 is at least 88% at rest on room air or baseline home oxygen for at least 12-24 hours, without significant desaturation with ambulation at baseline level; if hypercapnic on admission, pH is at least 7.35 and the member has been off noninvasive ventilation for at least 24 hours unless home noninvasive ventilation is planned; and the member can eat, sleep, and walk at or near baseline without severe dyspnea.Bronchodilator no more often than every 4 hours; SpO2 >=88%; pH >=7.35 if initially hypercapnic
Discharge treatment and planning: An oral corticosteroid course is prescribed, generally prednisone 40 mg daily to complete 5 days, with antibiotics when indicated, generally for 5-7 days; maintenance inhalers are reviewed and optimized; inhaler technique is confirmed; a written action plan is provided; home oxygen is ordered when indicated with reassessment planned; tobacco cessation counseling is documented if applicable; pulmonary rehabilitation referral is made; and follow-up is arranged within 1-4 weeks.Prednisone generally 40 mg daily for 5 days; antibiotics generally 5-7 days; follow-up 1-4 weeks

Continued acute inpatient stay

Continued acute inpatient stay is medically necessary when ANY of the following is documented:

Continued-stay criteria: Persistent respiratory acidosis or noninvasive ventilation dependence; bronchodilators are still needed more often than every 4 hours; a new complication such as pneumonia, heart failure, pulmonary embolism, or pneumothorax; oxygen requirement has not yet been weaned to a level manageable at home; or inability to take oral medications.Review every 24 hours, or every 12 hours when the member is on noninvasive or invasive ventilation

Does not meet criteria

The following scenarios do not meet medical-necessity criteria and are referred for physician review:

Does not meet criteria: Admission for a mild exacerbation with SpO2 of at least 92% and no respiratory distress; continued stay solely to start or change maintenance inhaler therapy or complete a corticosteroid course; continued stay solely for pulmonary rehabilitation enrollment or outpatient pulmonary function testing; continued stay solely to arrange home oxygen equipment delivery after the member is otherwise ready; or days awaiting skilled placement after discharge readiness criteria are met without an acute need.

These scenarios are not denied by an automated system or non-physician reviewer; refer for physician review and discharge planning.

This policy applies to acute COPD exacerbations. Pneumonia without a COPD exacerbation, acute respiratory failure from other causes, and asthma are outside its scope and should be evaluated under the applicable policy.

Admission for a mild COPD exacerbation with SpO2 ≥92% and no respiratory distress does not meet the policy’s medical-necessity criteria. These cases are generally appropriate for outpatient management and are referred for physician review rather than denied by an automated or non-physician reviewer.

A continued inpatient stay does not meet acute medical-necessity criteria when the only remaining reason is to start or change maintenance inhaler therapy, complete a corticosteroid course, enroll in pulmonary rehabilitation, perform outpatient pulmonary function testing, arrange home oxygen delivery after the member is otherwise ready for discharge, or await skilled placement after discharge readiness criteria are met. These situations require physician review and discharge planning.

Coding and Clinical Severity Definitions

ICD-10-CMICD-10

J44.0	COPD with acute lower respiratory infection or acute exacerbation
J44.1	COPD with acute lower respiratory infection or acute exacerbation

ICD-10-PCSICD-10

5A09357	Noninvasive and invasive ventilation (examples)
5A09457	Noninvasive and invasive ventilation (examples)
5A1935Z	Noninvasive and invasive ventilation (examples)
5A1945Z	Noninvasive and invasive ventilation (examples)
5A1955Z	Noninvasive and invasive ventilation (examples)

MS-DRG: COPDmixed

190	COPD
191	COPD
192	COPD

MS-DRG: respiratory failure and ventilator supportmixed

189	Respiratory failure and ventilator support
207	Respiratory failure and ventilator support
208	Respiratory failure and ventilator support

Revenue codesRevenue

0120	Revenue code
0200	Revenue code
0250	Revenue code
0300	Revenue code
0320	Revenue code
0410	Revenue code

Moderate exacerbation

Minimum findingsAt least 3 objective findings are required.

Clinical findingsDyspnea visual analog score of 5 or more; respiratory rate of 24 or more; or heart rate of 95 or more.

Oxygenation and inflammationResting SpO2 below 92% on room air or usual oxygen and/or a fall of more than 3%, or C-reactive protein of 10 mg/L or more.

Severe exacerbation

Required baselineMeets the moderate exacerbation criteria.

Hypercapnia

Documentation, Review, and Authorization Actions

Documentation Required

Inpatient Admission Criteria

Approve acute inpatient admission only when the record documents at least one clinical severity finding and at least one required hospital-level service.

Severity findings may include acute respiratory acidosis (pH below 7.35 with PaCO2 above 45 mm Hg), refractory hypoxemia, altered mental status, severe persistent dyspnea, failed initial emergency therapy, decompensated comorbidity, or DECAF score of 3 or more.
Hospital-level services may include noninvasive or invasive ventilation, high-flow oxygen, bronchodilators more often than every 4 hours with monitoring, controlled oxygen with repeat blood gases, IV therapy when oral medication cannot be taken, or inpatient treatment of a decompensated comorbidity.

Documentation Required

Level-of-Care Assignment

Assign the appropriate level of care based on the highest applicable criterion and document why the selected setting is required.

ICU: severe refractory dyspnea, worsening hypoxemia or acidosis despite treatment, invasive ventilation or anticipated intubation, mental-status change, or vasopressor-dependent instability.

Clinical Background

Acute COPD exacerbations are assessed using objective severity findings, including dyspnea, respiratory rate, heart rate, oxygen saturation, C-reactive protein, and arterial blood gas results. Placement of care also considers the member’s response to initial treatment, mental status, hemodynamic stability, serious comorbidities, home support, and ongoing treatment needs. Alternative or coexisting diagnoses—such as heart failure, pneumonia, pulmonary embolism, or pneumothorax—should be evaluated, and noninvasive ventilation is first-line for acute hypercapnic respiratory failure with acidosis.

Policy Definitions

Moderate exacerbation

DefinitionA moderate exacerbation requires at least 3 objective findings.

Respiratory findingsDyspnea visual analog score of 5 or more, respiratory rate of 24 or more, or heart rate of 95 or more.

Oxygenation or inflammationResting SpO2 below 92% on room air or usual oxygen and/or a fall of more than 3%, or C-reactive protein of 10 mg/L or more.

Severe exacerbation

DefinitionA severe exacerbation includes all moderate exacerbation criteria.

HypercapniaPaCO2 above 45 mm Hg on arterial blood gas.

Acidosis

Policy Summary

PayerCurative

PolicyAcute Exacerbation of Chronic Obstructive Pulmonary Disease

Policy CodePolicy CHP-IP-2026-016

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionFor acute inpatient admission, document at least one qualifying clinical severity finding and at least one required hospital-level service.

SourceLink

On This Page

PaCO2 above 45 mm Hg on arterial blood gas.

AcidosisArterial blood gas pH below 7.35.

Controlled oxygen

Target SpO2Maintain oxygen saturation at 88-92%.

TitrationTitrate oxygen to remain within the 88-92% SpO2 range.

Clinical purposeAvoid worsening hypercapnia.

Discharge oxygenation

Resting oxygenationSpO2 must be at least 88% at rest on room air or baseline home oxygen.

DurationResting oxygenation must remain stable for at least 12-24 hours.

AmbulationNo significant desaturation during ambulation at the member's baseline level.

Home oxygen qualification reference

Resting SpO2 thresholdResting SpO2 of 88% or less on room air qualifies for the home oxygen reference threshold.

PaO2 thresholdPaO2 of 55 mm Hg or less on room air qualifies for the home oxygen reference threshold.

Assessment settingQualification thresholds are assessed at rest on room air.

Step-down/intermediate: no ICU criterion, but noninvasive ventilation with pH 7.25–7.35 and improvement at 1–2 hours, high-flow oxygen with stable gas exchange, or weaning from noninvasive ventilation within 24 hours.

Medical-surgical: continued acute care without ICU or step-down criteria, such as bronchodilators every 2–4 hours with controlled low-flow oxygen or corticosteroids and antibiotics with oxygen weaning.

Prior Authorization

Continued-Stay Review

Support concurrent review when any continued-stay criterion is documented. Review every 24 hours, or every 12 hours when the member is receiving ventilation.

Persistent respiratory acidosis or dependence on noninvasive ventilation.
Bronchodilators still required more often than every 4 hours.
New pneumonia, heart failure, pulmonary embolism, pneumothorax, or other qualifying complication.
Oxygen requirement not yet weaned to a level manageable at home.
Inability to take oral medications.

Documentation Required

Discharge Readiness

Discharge only when all readiness, oxygenation, symptom, and treatment requirements are met and documented.

Short-acting bronchodilator is needed no more often than every 4 hours.
SpO2 is at least 88% at rest on room air or baseline home oxygen for 12–24 hours, without significant baseline-level ambulatory desaturation.
If hypercapnic on admission, pH is at least 7.35 and the member has been off noninvasive ventilation for at least 24 hours, unless home noninvasive ventilation is planned.
The member can eat, sleep, and walk at or near baseline without severe dyspnea.
Oral corticosteroids and indicated antibiotics are prescribed; maintenance inhalers are optimized, technique is confirmed, and a written action plan is provided.
Home oxygen is ordered when resting room-air SpO2 is 88% or less or PaO2 is 55 mm Hg or less, with reassessment planned; counseling, pulmonary rehabilitation referral, and follow-up within 1–4 weeks are documented.

Prior Authorization

Physician Review and Peer-to-Peer Required

Non-physician reviewers and automated systems may approve supported services in full or in part but may not issue an adverse determination. Route an unsupported request to a licensed physician of the same or similar specialty and offer the requesting provider a peer-to-peer discussion before any adverse determination.

The reviewing physician must meet applicable licensure, specialty, and medical-director requirements for the plan's situs state.

Billing Rule

Approve Supported Portion

When the service meets criteria but the requested quantity, units, or duration exceed what the documentation supports, approve the supported portion and refer only the unsupported increment for physician review.

Do not issue an adverse determination for the entire request solely because the requested extent exceeds the supported extent.

Documentation Required

Baseline Disease and Oxygen Status

Document the member's baseline COPD severity, usual home oxygen use, and prior exacerbation history.

Include baseline oxygen requirements and clinically relevant prior exacerbations.

Documentation Required

Current Respiratory Assessment

Document current vital signs, SpO2, oxygen-delivery device and flow, and the severity of dyspnea.

Record oxygen-delivery details with each clinically relevant saturation assessment.

Documentation Required

Blood Gas Assessment

Obtain and document an arterial or venous blood gas when SpO2 is below 92% or hypercapnia is suspected.

Include the blood-gas results in the admission or concurrent-review record.

Documentation Required

Evaluate Alternative Diagnoses

Document chest radiograph results and the evaluation for alternative diagnoses that could explain or complicate the exacerbation.

Address alternative diagnoses such as pneumonia, heart failure, pulmonary embolism, or pneumothorax when clinically relevant.

Documentation Required

Document Noninvasive Ventilation Response

For noninvasive ventilation, document the ventilation settings and the member's response at the 1–2 hour reassessment.

Include response in oxygenation, ventilation, respiratory effort, and acid-base status when available.

Documentation Required

Medication Regimen

Document the corticosteroid and antibiotic regimen, including dose when available, indication, and intended duration.

State when antibiotics are not indicated.

Documentation Required

Discharge Planning Documentation

Document the discharge inhaler plan, written action plan, oxygen assessment, and follow-up arrangements.

Include inhaler technique review and follow-up timing.

Prior Authorization

Support Requested Extent of Service

The requested service quantity, units, and duration must be supported by the clinical documentation and the applicable admission or continued-stay criteria.

Document the clinical need for the full requested extent of service.

Denial Risk

Mild Exacerbation May Be Outpatient

Flag admission for a mild exacerbation with SpO2 at least 92% and no respiratory distress as not meeting this policy's medical-necessity criteria; outpatient management is appropriate.

Refer the request for physician review; do not issue an automated or non-physician adverse determination.

Denial Risk

Identify Non-Acute Reasons for Continued Stay

Do not support continued acute stay solely for non-acute or discharge-planning reasons when no acute need remains. Refer these situations for physician review and discharge planning as applicable.

Changing or initiating maintenance inhaler therapy or completing a corticosteroid course; these can generally occur at discharge and follow-up.
Pulmonary rehabilitation enrollment or outpatient pulmonary function testing; these are wrong-site-of-care services.
Arranging home oxygen equipment delivery after the member is otherwise discharge-ready; this is a discharge-planning issue, and days already authorized are not retroactively denied.
Awaiting skilled placement after discharge-readiness criteria are met without an acute need; custodial days do not meet acute criteria, and days already authorized are not retroactively denied.
An expected length of stay is a planning benchmark, not a limit on covered days; apply concurrent review to each continued-stay period.

Prior Authorization

Physician Review Before Adverse Determination

Requests that do not meet the stated criteria must be routed to a licensed physician before any adverse determination.

Automated systems and non-physician clinical reviewers may not issue an adverse determination.

Denial Risk

Unsupported or Excess Services

Identify requests that are unsupported by the record, including excess quantities, units, or duration, and route the unsupported portion for physician review.

Approve the supported portion when applicable; review only the unsupported increment.
Do not retroactively deny days already authorized.

pH below 7.35 on arterial blood gas.

DECAF score

PurposeValidated in-hospital mortality score for COPD exacerbations.

Clinical domainsDyspnea, eosinopenia, and consolidation.

Additional domainsAcidemia and atrial fibrillation.

Low-risk rangeScores of 0-1 identify low risk suitable for early supported discharge or home treatment.

Controlled oxygen

Target rangeTitrate oxygen to an SpO2 of 88-92%.

ApplicationUse controlled oxygen during COPD exacerbation management.

ReasonThe target is intended to avoid worsening hypercapnia.